LE-Mantus Pharmaceuticals: A Pioneer Firm Promising Quality Veterinary Pharmaceutical Products

Ashutosh Gupta , Director

Ashutosh Gupta


The global veterinary medicine market is projected to grow at 8.2 percent CAGR over the forecast period, reaching $44.59 billion in 2022. The Indian Veterinary Healthcare Industry has assessed at $869.54 Mn in 2021 and is expected to grow at a 6.9 percent CAGR from 2022 to 2031. Factors such as increased demand for livestock products, an increase in the prevalence of various medical conditions in animals, an increase in livestock-keeping people, and an increase in animal healthcare spending are likely to contribute to the market's expansion over the analyzed timeline.

With the growing need for high-quality and affordable veterinary medicines in India, a number of significant players have come into prominence in the last couple of decades. One of the most prominent among them being LE-MANTUS PHARMACEUTICALS. A fully integrated, growing pharmaceutical company, LE-MANTUS is known for manufacturing a broad variety of high-quality, affordable veterinary medicines that are trusted, prescribed, and used by veterinary healthcare professionals throughout India. The company was founded in 2003 with the goal of becoming a pioneer in the manufacturing and supply of high-quality but affordable pharmaceutical products, and over the decades, the firm has certainly achieved this status.

Range of Offerings

As a leading veterinary pharmaceuticals manufacturer, LE-MANTUS has developed a comprehensive product portfolio over the years. The firm’s range of offerings can be categorized into five major segments including Bolus and Tablets, Dry Injections, Liquid Injections, Milk Enhancers and Dewormers, and External products (Ecto and Endo- Parasitic). Within these categories, the organization develops hundreds of products to meet varied veterinary needs. “Through our module of products, we aim to make quality affordable. We provide a range of medications developed to resolve the common challenges of the industry like costly, substandard quality, improper packaging, and more. Our medicines are known for their high and consistent quality, are result-oriented, and are reliable for promoting animal health. This has been made possible because  we follow international quality standards and all the medicines are manufactured as per directives by WHO and as per GMP”, shares Ashutosh Gupta, Director, LE-MANTUS PHARMACEUTICALS. To date, while hundreds of products are being developed by the firm, and many more are in the pipeline, the company’s flagship product is Tivomac which is available in many variations. This allows vets to select the right solution for the kind of animal ailment they are dealing with.

Charting the Path Ahead

LE-MANTUS was set up with the vision to be a key global pharmaceutical company with an increasing focus on ethics, innovative research, unmatched quality, and service through affordable and accessible health care. The tremendous hard work, dedication, and teamwork of every associate have made LE-MANTUS strong since the beginning. The journey for this company has been no less than an inspiring tale. Today, LE-MANTUS stands with a team of 100+ employees working diligently across the length and breadth of India.

As a leading veterinary Pharmaceuticals Manufacturer, LEMANTUS Has developed A comprehensive product Portfolio over the years

Ashutosh Gupta , Director

The company’s module of products stands among the top five in the country which says a lot, considering how competitive this industry is. This has all been possible because of the sheer commitment to quality and affordability of products. “Since consistent quality, reliability, and effectiveness are the three core qualities which set us apart from the competition, we have a lot of measures to ensure meeting these standards. For instance, quality checks on the API procurement, testing, and also in every process cycle of drug production we take utmost care to follow all department, GMP & WHO guidelines. To ensure that results in each product should remain consistent, we use the advanced methods of production, eliminating chances of human error”, further shares Ashutosh.

For the coming years, the organization has made elaborate plans, with some already set in motion. LEMANTUS is striving to expand its portfolio across the various veterinary sectors except for Bovine medicines. The company has already launched an ingenious digital product with the aim of connecting directly with the customers and getting very good responses to it also. Many more innovative digital products are in the pipeline which will not only help the company to grow its user base but also ease the life of consumers through those products. These products are also aimed at helping consumers in their savings by reducing the maintenance expenses of the livestock. In short, in the coming years, customers can not only expect consistent quality & affordable medicines but also digital tools which will help in reducing their expenditure on livestock maintenance. When LE-MANTUS says that it also observes social responsibility, the firm leaves no stone unturned to prove it through its initiatives.

© 2024 India Pharma Outlook. All Rights Reserved.